1. Blanco-Luquin, Idoia, Acha, Blanca, Urdánoz-Casado, Amaya, Cabello, Juan, Mendioroz, Maite. 2022. NXN Gene Epigenetic Changes in an Adult Neurogenesis Model of Alzheimer's Disease. In Cells, 11, . doi:10.3390/cells11071069. https://pubmed.ncbi.nlm.nih.gov/35406633/
2. Zhang, Yuanping, Zuo, Dinglan, Qiu, Jiliang, Yuan, Yunfei, Li, Binkui. 2022. NXN suppresses metastasis of hepatocellular carcinoma by promoting degradation of Snail through binding to DUB3. In Cell death & disease, 13, 676. doi:10.1038/s41419-022-05135-7. https://pubmed.ncbi.nlm.nih.gov/35927236/
3. Zhang, Chaofan, Jolly, Angad, Shayota, Brian J, Sutton, V Reid, Carvalho, Claudia M B. 2021. Novel pathogenic variants and quantitative phenotypic analyses of Robinow syndrome: WNT signaling perturbation and phenotypic variability. In HGG advances, 3, 100074. doi:10.1016/j.xhgg.2021.100074. https://pubmed.ncbi.nlm.nih.gov/35047859/
4. Idelfonso-García, Osiris Germán, Alarcón-Sánchez, Brisa Rodope, Vásquez-Garzón, Verónica Rocío, Pérez-Carreón, Julio Isael, Arellanes-Robledo, Jaime. 2022. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies. In Antioxidants (Basel, Switzerland), 11, . doi:10.3390/antiox11040670. https://pubmed.ncbi.nlm.nih.gov/35453355/
5. Arellanes-Robledo, Jaime, Reyes-Gordillo, Karina, Ibrahim, Joseph, Shah, Ruchi, Lakshman, M Raj. 2018. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro. In Biochemical pharmacology, 156, 135-146. doi:10.1016/j.bcp.2018.08.021. https://pubmed.ncbi.nlm.nih.gov/30125555/
6. Zhang, Chaofan, Mazzeu, Juliana F, Eisfeldt, Jesper, Sutton, V Reid, Carvalho, Claudia M B. 2020. Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome. In American journal of medical genetics. Part A, 185, 3593-3600. doi:10.1002/ajmg.a.61908. https://pubmed.ncbi.nlm.nih.gov/33048444/
7. Arcaroli, John J, Touban, Basel M, Tan, Aik Choon, Gao, Dexiang, Messersmith, Wells A. 2010. Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 16, 4165-77. doi:10.1158/1078-0432.CCR-10-0066. https://pubmed.ncbi.nlm.nih.gov/20682712/